Israeli agtech company Kaiima Bio-Agritech has selected St. Louis as the location of its U.S. headquarters thanks in part to the efforts of BioSTL, a St. Louis organization supporting the local innovation ecosystem and bioscience sector.
Kaiima’s decision represents the first success of BioSTL’s newly-launched initiative targeting Israeli companies for recruitment.
Kaiima is an Israel-based plant genetics and breeding-technology company that has developed a non-GMO technology platform that improves crop productivity. Founded in 2007, the company has raised $98 million in multiple venture capital financings.
BioSTL’s newly-launched St. Louis-Israel Innovation Connection initiative establishes a direct pipeline for business interaction between St. Louis and the country of Israel, with the aim of recruiting Israeli companies that are seeking to establish a U.S. presence and that are aligned with St. Louis’ business, scientific and technological strengths.
The SLIIC team identifies and screens prospective target companies and matches these Israeli companies with St. Louis resources, including potential corporate and institutional partners, investors, and scientific and business expertise that can lead to establishing a company presence in St. Louis.
